ETS variant gene 6 (ETV6), which belongs to the E26 transformation-specific (ETS) transcription factor family, was suggested to play a role as a tumor suppressor due to observed deletions in last stage, advanced prostate cancer [1–4]; however, its biological functions remain unclear. Here, ETV6 is linked to prostate carcinoma.